Therapeutic Advances in Vaccines and Immunotherapy

eISSN: 2515-1363pISSN: 2515-1355
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
6.5
H-Index
10
SJR
Q2Oncology
SNIP
1.11
5
Time to Publish
time-to-publish View Chart
6  Mo

Journal Specifications

Indexed in the following public directories

  • Scopus
  • DOAJ
  • SJR
Overview
  • Publisher
    SAGE
  • Language
    English
  • Publication Time
    8
  • Editorial Review Process
    Anonymous peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

check-iconMeets Top Publisher Standards: Essential for leading journals like Elsevier.
check-iconEnhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
check-iconTailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn morethumb-icon 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 11%
4-6 39%
7-9 17%
>9 33%

Topics Covered

Immunization
Immunotherapy
Human papillomavirus vaccination
Influenza vaccine
Clinical trial
Pertussis vaccine

Recently Published Papers

Year-wise Publication

FAQs

What is the H-index. SNIP score, Citescore and SJR of Therapeutic Advances in Vaccines and Immunotherapy? Faqs

Therapeutic Advances in Vaccines and Immunotherapy has a H-index score of 10, Citescore of 6.5, SNIP score of 1.11, & SJR of Q2

Who is the publisher of Therapeutic Advances in Vaccines and Immunotherapy? Faqs

The publisher of Therapeutic Advances in Vaccines and Immunotherapy is SAGE.

How can I view the journal metrics of Therapeutic Advances in Vaccines and Immunotherapy on editage? Faqs

For the Therapeutic Advances in Vaccines and Immunotherapy metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Therapeutic Advances in Vaccines and Immunotherapy? Faqs

The eISSN number is 2515-1363 and pISSN number is 2515-1355 for Therapeutic Advances in Vaccines and Immunotherapy.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Immunization, Immunotherapy, Human papillomavirus vaccination, Influenza vaccine, Clinical trial, Pertussis vaccine.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.